The UK BioBank is expected to collect its 500,000 sample this summer. This government funded-initiative was developed to collect genetic samples and clinical information, following participants over time to better understand links between genetic variations, behavior and ethnic background.
The National Cancer Institute Office of Biorepositories and Biospecimen Research (OBBR) convened the 3rd Annual Biospecimen Research Network (BRN) Symposium: Advancing Cancer Research Through Biospecimen Science, on March 24-25. This meeting discussed the current state of biospecimen collection and goals for the future. The lack of high quality biospecimens is a great challenge in research. In fact, poor specimen quality may compromise research. There is an ongoing focus on the impact of preanalytical variables (e.g. antibiotics, systemic drugs, clamp time for surgery, etc.) on sample integrity. The development, education, and use of best practices and SOPS were reiterated throughout the meeting. Interoperability was also encouraged through ethical and legal processes, data management, and sample management. The meeting concluded with a session describing the Cancer Human Biobank (caHUB) initiative.
Genetic Alliance BioBank Grant Due May 1
To build capacity and advance novel partnerships, Genetic Alliance is offering one grant of $20,000, to be awarded to a single or multi-group organization or consortium towards the start-up fee for membership in the Genetic Alliance BioBank.